Literature DB >> 17394463

Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo.

Minchan Gil1, Cushla McKinney, Mi Kyeong Lee, Jeffrey B Eells, Marcia A Phyillaier, Vera M Nikodem.   

Abstract

Nurr1 is an orphan nuclear transcription factor essential for the terminal differentiation of dopamine (DA) neurons in the ventral midbrain (VM). To identify the Nurr1-target genes, we carried out microarray and quantitative real-time PCR analyses of Nurr1 null and wild-type mice in VM at embryonic day (E) 12.5 and shortly after birth (P0). In addition to the absence of mRNAs of DA synthesizing enzymes, the guanosine 5'-triphosphate (GTP) cyclohydrolase I (GTPCH) was also substantially reduced in the VM of Nurr1-null mice. GTPCH is the first enzyme in the synthesis pathway of tetrahydrobiopterin (BH4), an essential cofactor for tyrosine hydroxylase in DA synthesis. In the mouse, Nurr1 and GTPCH mRNA were first detected at E10.5, and GTPCH transcription paralleled that of Nurr1. Small interfering RNA targeted against Nurr1 decreases GTPCH expression in MC3T3-E1 osteoblasts in cell culture. Cotransfection of Nurr1 and the GTPCH-luciferase (luc) reporter increased the luc activity by about threefold in N2A cells. Additional analysis using 5'-deletions and mutants revealed that Nurr1 activates GTPCH transcription indirectly through the proximal promoter region, in the absence of the nerve growth factor-induced clone B (NGFI-B) responsive element-like sites, similarly, as recently reported for DA transporter regulation by Nurr1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17394463     DOI: 10.1111/j.1471-4159.2006.04356.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

2.  Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.

Authors:  Pengxiang Tian; Weibo Shi; Jie Liu; Jie Wang; Chunling Ma; Qian Qi; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Authors:  Athanasios D Spathis; Xenophon Asvos; Despina Ziavra; Theodoros Karampelas; Stavros Topouzis; Zoe Cournia; Xiaobing Qing; Pavlos Alexakos; Lisa M Smits; Christina Dalla; Hardy J Rideout; Jens Christian Schwamborn; Constantin Tamvakopoulos; Demosthenes Fokas; Demetrios K Vassilatis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 4.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

5.  Gene expression profiling in rodent models for schizophrenia.

Authors:  Jessica E Van Schijndel; Gerard J M Martens
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  Structure of distress call: implication for specificity and activation of dopaminergic system.

Authors:  Subramanian Mariappan; Wieslaw Bogdanowicz; Hanumanthan Raghuram; Ganapathy Marimuthu; Koilmani Emmanuvel Rajan
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2015-11-26       Impact factor: 1.836

Review 7.  Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.

Authors:  Md Jakaria; Md Ezazul Haque; Duk-Yeon Cho; Shofiul Azam; In-Su Kim; Dong-Kug Choi
Journal:  Mol Neurobiol       Date:  2019-01-25       Impact factor: 5.590

8.  NR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes.

Authors:  Jeffrey B Eells; Josiah Wilcots; Scott Sisk; Shirley X Guo-Ross
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

9.  The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes.

Authors:  Magen M Johnson; Sharon K Michelhaugh; Mohamad Bouhamdan; Carl J Schmidt; Michael J Bannon
Journal:  Front Neurosci       Date:  2011-12-20       Impact factor: 4.677

10.  Region Specific Effects of Aging and the Nurr1-Null Heterozygous Genotype on Dopamine Neurotransmission.

Authors:  Evangel Kummari; Shirley Guo-Ross; Jeffrey B Eells
Journal:  Neurochem Neuropharmacol       Date:  2017-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.